Dual Disease Burden: Growing Older with Congenital Heart Disease and Hereditary Metabolic and Connective Tissue Disorders—Data from the PATHFINDER-CHD Registry on Heart Failure
Authors:
- Ann-Sophie Kaemmerer-SuleimanAnn-Sophie Kaemmerer-Suleiman
- Frank HarigFrank Harig
- Annika FreibergerAnnika Freiberger
- Oliver DewaldOliver Dewald
- Stephan AchenbachStephan Achenbach
- Aysenur AkyolAysenur Akyol
- Helena DreherHelena Dreher
- Anna EngelAnna Engel
- Peter EwertPeter Ewert
- Sebastian FreilingerSebastian Freilinger
- Jürgen HörerJürgen Hörer
- Christopher HohmannChristopher Hohmann
Open Access
- 20 November 2025
- journal article
- research article
- Published by MDPI AG in Geriatrics
- Vol. 10 (6) , 152
Abstract
Background: Advances in diagnosis and treatment have led to a growing population of adults with congenital heart disease (ACHD). Despite increasing life expectancy, their clinical needs—especially in older age—remain poorly defined. Cardiac and non-cardiac comorbidities are prevalent, and emerging evidence suggests accelerated biological aging compared to the general population. However, data on older patients and geriatric patients with CHD are limited. Objectives: This study aimed to characterize patients with CHD aged ≥50 years, focusing on functional status, comorbidities, sex-specific differences, and therapeutic patterns. Methods: The PATHFINDER-CHD Registry is a prospective, observational, multicenter registry enrolling patients with CHD with manifest heart failure (HF), HF history, or high HF risk. Data include anatomy, prior treatments, comorbidities, and medication use. Results: Among 1935 patients, 297 were ≥50 years old. Most had acyanotic CHD (62%); Tetralogy of Fallot (21%) was the most frequent diagnosis. A morphologic right systemic ventricle was present in 12%, and 5% had univentricular hearts. HF was manifest in 21%; 44% were classified as ACC/AHA stage B, 51% as stage C, yet 77% were in Perloff class I/II. Common cardiovascular comorbidities included aortopathy (55%), hypertension (37%), and arrhythmia (33%). Non-cardiac comorbidities included thyroid dysfunction (25%), renal impairment (18%), and neurological disease (13%). Sex-specific differences were observed. Despite HF burden, SGLT2 inhibitors and ARNIs were used in only 17% and 8.4%, respectively. Conclusions: Older patients with CHD represent a clinically complex cohort with high comorbidity burden. The findings support the concept of accelerated aging and emphasize the need for tailored interdisciplinary care strategies.Keywords
Funding Information
- Manfred Roth Stiftung Fürth
This publication has 29 references indexed in Scilit:
- A Systematic Review and Meta-Analysis of the Safety and Efficacy of SGLT2 Inhibitors in Chronic Heart Failure in ACHD PatientsAmerican Journal of Cardiovascular Drugs, 2024
- The Appraisal of Adults with Congenital Heart Disease: Lesson from Comparison of Surgical OutcomesPediatric Cardiology, 2024
- Experience with SGLT2 Inhibitors in Patients with Single Ventricle Congenital Heart Disease and Fontan Circulatory FailurePediatric Cardiology, 2023
- Adult Congenital Heart Disease in the Aging and Elderly PopulationCurrent Geriatrics Reports, 2023
- “Adults with congenital heart defects”: current challenges in medical care. Part II: infective endocarditis, pulmonary hypertension, aortopathy, cardiac surgical aspects, psychocardiology, unresolved problems and future aspectsDie Kardiologie, 2023
- „Erwachsene mit angeborenen Herzfehlern“: Aktuelle Herausforderung in der medizinischen Versorgung Teil I: Versorgungsstruktur und Problematik, Herzinsuffizienz, HerzrhythmusstörungenDie Kardiologie, 2023
- Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart DiseaseCanadian Journal of Cardiology, 2022
- Sacubitril/Valsartan in Adult Congenital Heart Disease Patients With Chronic Heart Failure − A Single Centre Case Series and Call for an International RegistryHeart, Lung and Circulation, 2020
- The care of adults with congenital heart disease across the globe: Current assessment and future perspectiveInternational Journal of Cardiology, 2015
- Geriatric Congenital Heart DiseaseJACC, 2011